
ElectroCore, Inc., a bioelectronic medicine and wellness company, has been granted two patents by the United States Patent and Trademark Office (USPTO). The first patent (US Patent No. 11,850,056) focuses on remote therapy and patient monitoring, detailing a system for delivering non-invasive vagus nerve stimulation (nVNS) therapy while monitoring heart rate variability. The second patent (US Patent No. 11,854,695) pertains to medical devices treating conditions with electrical impulses, deactivating after a specified number of doses or elapsed time. ElectroCore is committed to enhancing health through its nVNS technology platform.
Like
Save
Share